- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||lenzilumab|
|Search PubMed titles||lenzilumab|
|Search PubMed titles/abstracts||lenzilumab|
|Lenzilumab is a fully human IgG1κ moncolonal antibody targeting granulocyte-macrophage colony-stimulating factor (GM-CSF), being investigated for its immunomodulatory potential.
Peptide sequences for this antibody are available from its IMGT/mAb-DB record.
BLAST peptide searches using the variable regions of the heavy and light chains of the antibody reveal exact matches with sequences submitted with patent US8075885 B2 .